Prof. Vladimír Dvořák shares his perspective on the evolving management of CIN2 in Europe, where clinicians are becoming increasingly conservative for young women with fertility preservation needs.
He discusses the potential value of Cevira, a portable photodynamic therapy, as a non-excisional treatment option for selected CIN2 patients, especially those with small, exocervical lesions, visible squamocolumnar junction, and reliable follow-up.
For patients who wish to avoid unnecessary surgery but still prefer active treatment rather than observation alone, Cevira may offer a promising fertility-preserving approach.